BC Platforms, a Zurich, Switzerland-based company which specializes in healthcare data management and analytics, acquired Medexprim, a Paris, and Toulouse, France-based real-world data company.
The amount of the deal was not disclosed.
The acquisition expands BC Platforms’ ability to provide global biopharma partners with secure access to real-world clinical and imaging data assets across Europe.
Led by CEO Romain Cazavan, Medexprim builds bridges between European academic hospitals, and life sciences, AI and medical device companies. It provides its partners with regulatory-grade, multimodal and multicentric datasets to help solve the “one patient, one disease, one treatment” equation, and accelerate personalized medicine. The company employs 35 industry experts in Toulouse, France (Center of excellence for R&D) and Paris (Commercial HQ).
Led by CEO Tero Silvola, BC Platforms is a global leader in building data networks for the life sciences industry and provides technology platforms for personalized medicine, accelerating the translation of innovations into clinical practice.
The company has operations with its headquarters in Zurich, Switzerland, R&D in Espoo, Finland, and Singapore, as well as a presence in London, UK, Lund, Sweden, Toulouse, France and Boston, USA.
This acquisition follows BC Platforms’ recent addition of 4Pharma in Europe.
FinSMEs
07/12/2023